RecallDepth
Class II Terminated

Bromocriptine Mesylate Capsules USP, 5 mg, 30-count bottles, Rx only, Manufactured by: Cadila Healthcare ltd., Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534, NDC 68382-110-06

Company
Zydus Pharmaceuticals (Usa) Inc
Recall Initiated
May 9, 2016
Posted
September 14, 2016
Recall Number
D-1491-2016
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
14,808 bottles
Firm Location
Pennington, NJ, United States

Reason for Recall

Failed impurities/degradation specifications: Out of specification results noticed in related substance test during analysis of 24 months long term (25 degree Celsius /65% RH) stability samples of two batches.

Distribution

US Nationwide

Lot / Code Info

Lot # MP993, Exp10/16; MR2704, Exp 02/17; MR6851, MR8100; Exp 07/17 and MR1210, Exp 12/17

More recalls by Zydus Pharmaceuticals (Usa) Inc

View all recalls by this company →

Other recent Class II Drug recalls